215380 — Woojung BIO Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Woojung BIO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-10,879	-1,926	-1,880	-5,054	225
Depreciation
Amortisation
Non-Cash Items	8,696	-1,047	623	2,225	114
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7,977	1,999	-488	-4,716	-5,667
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-8,575	1,728	2,502	-3,222	-1,126
Capital Expenditures	-16,639	-36,721	-11,510	-887	-310
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,673	7,285	5,323	1,023	-738
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-18,312	-29,437	-6,187	136	-1,048
Financing Cash Flow Items	-83.8	173	-346	27.4	186
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	26,343	24,056	6,807	4,925	776
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-596	-3,653	3,122	1,840	-1,397